As a supporting partner to medical practitioners throughout the world, Medmain develops and operates PidPort, an analytical system for pathological image diagnosis that makes use of Deep Learning, as well as Medteria, a specialized cloud-based service for medical students.
PidPort is an analytical system for pathological image diagnosis that enables super-precise, prompt pathological diagnosis using our unique Deep Learning/AI-based image processing technology. PidPort also features a remote pathological diagnosis function that leverages cloud network technology.*
AI-based pathological screening
PidPort enables highly precise and instantaneous screening of pathologic tissue and cells using AI independently developed by Medmain. As an assistant to medical practitioners, the system eases one's daily workflow.*
Globally-linked remote pathological diagnosis
PidPort's telepathology (remote pathological diagnosis) function enables optimal, timely pathological diagnosis requests and support via a network of medical practitioners around the world.
Optimal storage space for pathologic specimens
Digitization enables cloud-based management and storage of pathologic image data and case histories without the need to worry about deterioration or physical storage space.
*It is depending on the country and region, all or a certain feature are available for use. Please contact us for details.
We gave a presentation at NRW Japan K.K. Fireplace Talk!
Collaborative research between Medmain and the National Hospital Organization Kyushu Medical Center will be presented at the American Society of Clinical Oncology (ASCO) 2020!
Our CEO was selected for the Forbes 30 Under 30 Asia!!